Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus

Emerging Infectious Diseases

Volumn 8, Issue 8, 2002, Pages 802-807

  Carmeli, Yehuda ^a,b   Eliopoulos, George M ^a,b   Samore, Matthew H ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CARDIOVASCULAR DISEASE; CLOSTRIDIUM DIFFICILE; COMORBIDITY; CONTROLLED STUDY; ENTEROCOCCUS; FEMALE; GASTROINTESTINAL DISEASE; HOSPITAL ADMISSION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; RISK FACTOR;

EID: 0036686038     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0808.010418     Document Type: Article

References (32)

1. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium
2. Vancomycin-resistant enterococci
3. National nosocomial infections surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) system
4. Evolution of structure and substrate specificity in D-alanine: D-alanine ligases and related enzymes
5. Influence of oral glycopeptides on the fecal flora of human volunteers: Selection of highly glycopeptide-resistant enterococci
6. Vancomycin-resistant enterococci in intensive-care hospital settings: Transmission dynamics, persistence, and the impact of infection control programs
7. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: An important infection control variable
8. Emergence of vancomycin-resistant enterococci in New York City
9. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance
10. Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: Duration of stool shedding and incidence of clinical infection
11. Vancomycin-resistant Enterococcus faecium in hospitalized children
12. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center
13. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections
14. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients
15. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit
16. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers
17. Relative importance of oral versus intravenous vancomycin exposure in the development of vancomycin-resistant enterococci
18. Epidemiology of colonization of patients and environment with vancomycin-resistant enterococci
19. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit
20. The association between vancomycin treatment and hospital-acquired vancomycin-resistant enterococci (VRE): A meta-analysis
21. Vancomycin-resistant enterococci in intensive care units: High frequency of stool carriage during a non-outbreak period
22. A clinical data repository enhances hospital infection control
23. Vancomycin-resistant enterococcal infections
24. Control group selection is an important but neglected issue in the studies of antibiotic resistance
25. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: A systematic review
26. Effects of antibiotics on nosocomial epidemiology of vancomycin resistant enterococci (VRE)
27. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units
28. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gramnegative bacilli
29. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection?
30. Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract
31. Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract
32. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients